Holen Sie sich die Stockscreener-App
5.485
2.72%
0.145
Schlusskurs vom Vortag:
$5.34
Offen:
$5.26
24-Stunden-Volumen:
218.35K
Relative Volume:
0.15
Marktkapitalisierung:
$712.96M
Einnahmen:
$204.17M
Nettoeinkommen (Verlust:
$-74.00M
KGV:
-9.4978
EPS:
-0.5775
Netto-Cashflow:
$-12.84M
1W Leistung:
+1.67%
1M Leistung:
+3.88%
6M Leistung:
+18.47%
1J Leistung:
+31.53%
1-Tages-Spanne:
$5.24
$5.505
1-Wochen-Bereich:
$5.19
$5.49
52-Wochen-Spanne:
$3.31
$6.21
Cytek Biosciences Inc Stock (CTKB) Company Profile
Firmenname
Cytek Biosciences Inc
Sektor
Branche
Telefon
(877) 922-9835
Adresse
47215 LAKEVIEW BOULEVARD, FREMONT
Compare CTKB vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
5.485 | 712.96M | 204.17M | -74.00M | -12.84M | -0.5775 |
ABT
Abbott Laboratories
|
98.61 | 170.62B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
93.39 | 119.46B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
294.48 | 112.95B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.14 | 63.97B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.72 | 50.56B | 6.30B | 1.07B | 1.09B | 1.8406 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2025-05-09 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-31 | Herabstufung | Goldman | Buy → Sell |
| 2023-12-14 | Eingeleitet | Stephens | Overweight |
| 2023-07-19 | Eingeleitet | Raymond James | Mkt Perform |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
Alle ansehen
Cytek Biosciences Inc Aktie (CTKB) Neueste Nachrichten
Cytek Biosciences Stock Price Forecast. Should You Buy CTKB? - StockInvest.us
Cytek Biosciences (NASDAQ:CTKB) Updates Bylaws Following $56.1 Million Patent Verdict - Kalkine Media
Form 8K Cytek Biosciences Inc For: 29 September By Investing.com - Investing.com Nigeria
Fund Divests Cytek Biosciences (CTKB) Following Revenue Slowdown and Declining Profitability - finance.yahoo.com
A new tool lets researchers analyze cell data online without rebuilding their work - Stock Titan
Cytek Biosciences stock trades near recent lows after valuation update - AD HOC NEWS
Cytek Biosciences stock edges higher after recent earnings and analyst interest - AD HOC NEWS
Is the Options Market Predicting a Spike in Cytek Biosciences Bank Stock? - Eastern Progress
3 Promising Penny Stocks With Market Caps Over $100M - Simply Wall Street
Cytek Biosciences, Sysmex Europe Collaborate to Deliver Clinical Flow Cytometry Workflows - marketscreener.com
Sysmex Europe SE And Cytek Biosciences, Inc Collaborate To Expand Access To Advanced Clinical Flow Cytometry - marketscreener.com
Sysmex Europe SE and Cytek Biosciences Announce Strategic Collaboration to Expand Clinical Flow Cytometry Access Across Europe - Quiver Quantitative
Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry - Yahoo Finance
European labs can combine routine testing with advanced leukemia and lymphoma analysis - Stock Titan
Cytek’s (CTKB) Instruments Keep Selling While Losses Keep Growing - Yahoo Finance
Cytek Biosciences to Showcase Spectral Flow Cytometry Solutions at ESCCA 2026 and ICCS 2026 - Quiver Quantitative
Cytek Biosciences Showcases Advanced Spectral Flow Cytometry Solutions At Escca and Iccs - marketscreener.com
Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS - Yahoo Finance
Cytek Biosciences (CTKB) officer plans $146K share sale - Stock Titan
Cytek Biosciences stock holds near recent levels as investor conferences approach - AD HOC NEWS
Cytek Biosciences to Participate in Upcoming Investor Conferences - GlobeNewswire
Cytek Owes Beckman Coulter $56 Million at Patent Jury Trial (2) - Bloomberg Law News
Cytek Biosciences Shares Drop After Jury Says It Owes $56 Million in Damages - marketscreener.com
Cytek (CTKB) Earnings Report: EPS Clears the Reported Estimate in Latest Trading; Price Reaction: Shares Finish 3.22% Up in the Latest SessionPre-Announcement Alert - vinanet.vn
Cytek Hit With $56M Verdict For Infringing Cell-Sorting Patent - Law360
Cytek Biosciences wins on three of four patent claims - Investing.com
Cytek Biosciences wins on three of four patent claims By Investing.com - Investing.com Nigeria
Cytek Biosciences wins on three of four patent claims By Investing.com - Investing.com Canada
Jury Finds in Cytek’s Favor on Three of Four Asserted Claims; Company to Challenge Remaining Finding - marketscreener.com
Cytek products remain available worldwide after jury awards $36M in royalties - Stock Titan
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says - Reuters
Cytek Biosciences CFO William D. McCombe Executes RSU Vesting and Tax Withholding Transactions - Kalkine Media
Cytek Biosciences Director Glenn P. Muir Converts 3,086 RSUs to Common Stock on August 18, 2026 - Kalkine Media
Cytek Biosciences (CTKB) CEO gets 120K shares, surrenders some for taxes - Stock Titan
Cytek Biosciences (NASDAQ: CTKB) director gains 3,086 no-cost shares - Stock Titan
Cytek Biosciences (CTKB) director now holds 28,499 shares - Stock Titan
Cytek Biosciences (CTKB) CTO gets 33,270 shares, surrenders some for taxes - Stock Titan
Cytek (CTKB) Quarterly Figures: EPS Prints Above Forecast in the Latest Session; Stock Move: Shares Finish 0.96% HigherEstimate Dispersion - vinanet.vn
Cytek Biosciences CEO Wenbin Jiang Completes RSU Vesting and Tax Withholding Share Surrender - Kalkine Media
Cytek Biosciences Balances Growth With Profit Pressures - TipRanks
Cytek (CTKB) Q2 2026 Earnings Call Transcript - AOL.com
Cytek Biosciences (CTKB) awards 241,416 RSUs and 127,118 options to top lawyer - Stock Titan
Cytek (CTKB) Q2 2026 Earnings Call Transcript - The Globe and Mail
Cytek Biosciences: Recurring Revenue Reaches 35% Of Sales As Installed Base Approaches 4,000 Instruments - Pulse 2.0
Cytek Biosciences launches Aurora Evo system to drive high-throughput research and small particle detection - Traders Union
Promising Penny Stocks To Consider In August 2026 - simplywall.st
Promising Penny Stocks To Consider In August 2026 - simplywall.st
Cytek Biosciences (NASDAQ:CTKB) Trading 8.5% HigherShould You Buy? - MarketBeat
Cytek Biosciences, Inc. (8EQ.MU) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (ZBH), Cytek Biosciences (CTKB) and Sight Sciences (SGHT) - The Globe and Mail
Finanzdaten der Cytek Biosciences Inc-Aktie (CTKB)
Umsatz
Nettogewinn
Free Cashflow
ENV
8.93%
0.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):